The randomized, double-blind, 2-arm parallel group Phase II study of BEKINDA™ 12 mg is ...
Dublin, Nov. 16, 2017 (GLOBE NEWSWIRE) -- The "HIV Testing Market (Immunoassay, Molecular, Point-of-Care ...
Posters include intranasal and oral HAP data for serdexmethylphenidate (SDX), as well as PK ...
